Večerić-Haler Ž - Search Results

1

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review.

Bele D, Kojc N, Perše M, Černe Čerček A, Lindič J, Aleš Rigler A, Večerić-Haler Ž. Bele D, et al. BMC Nephrol. 2020 Jan 31;21(1):40. doi: 10.1186/s12882-020-1694-2. BMC Nephrol. 2020. PMID: 32005179 Free PMC article. Review.

2

Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin.

Večerić-Haler Ž, Erman A, Cerar A, Motaln H, Kološa K, Lah Turnšek T, Sodin Šemrl S, Lakota K, Mrak-Poljšak K, Škrajnar Š, Kranjc S, Arnol M, Perše M. Večerić-Haler Ž, et al. Stem Cells Int. 2016;2016:3585362. doi: 10.1155/2016/3585362. Epub 2016 Jan 5. Stem Cells Int. 2016. PMID: 26880955 Free PMC article.

3

Tubular urinary indexes reliably distinguish between primary tubulointerstitial and primary glomerular diseases in patients referred for kidney biopsy.

Škoberne A, Borštnar Š, Avguštin N, Kovač D, Rigler AA, Večerić-Haler Ž, Pajek J, Krsnik M, Kojc N, Ferluga D, Lindič J. Škoberne A, et al. Clin Nephrol. 2017 Supplement 1;88(13):1-6. doi: 10.5414/CNP88FX01. Clin Nephrol. 2017. PMID: 28601117

4

Rhabdomyolysis and interferon-β: case report and short review.

Jerman A, Kovač D, Večerić-Haler Ž, Hočevar A, Ota A, Banović S, Lindič J. Jerman A, et al. Clin Nephrol. 2017 Supplement 1;88(13):32-34. doi: 10.5414/CNP88FX08. Clin Nephrol. 2017. PMID: 28655386 Review.

5

Rituximab for the treatment of membranous nephropathy: a single-center experience.

Aleš Rigler A, Jerman A, Orsag A, Kojc N, Kovač D, Škoberne A, Borštnar Š, Večerić Haler Ž, Avguštin N, Kveder R, Ferluga D, Vizjak A, Lindič J. Aleš Rigler A, et al. Clin Nephrol. 2017 Supplement 1;88(13):27-31. doi: 10.5414/CNP88FX07. Clin Nephrol. 2017. PMID: 28664837

6

Treatment of antibody-mediated rejection of kidney grafts with bortezomib and/or rituximab compared to standard regimen: experience of Slovene National Center.

Oblak T, Lindič J, Gubenšek J, Kveder R, Aleš Rigler A, Škoberne A, Večerić Haler Ž, Borštnar Š, Avguštin N, Ponikvar R, Mlinšek G, Ferluga D, Kojc N, Godnov U, Kovač D. Oblak T, et al. Clin Nephrol. 2017 Supplement 1;88(13):91-96. doi: 10.5414/CNP88FX21. Clin Nephrol. 2017. PMID: 28664838

7

(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity.

Večerić-Haler Ž, Cerar A, Perše M. Večerić-Haler Ž, et al. Stem Cells Int. 2017;2017:7304643. doi: 10.1155/2017/7304643. Epub 2017 Dec 12. Stem Cells Int. 2017. PMID: 29379525 Free PMC article. Review.

8

Early Graft Loss after Kidney Transplantation: Endothelial Dysfunction of Renal Microvasculature.

Kojc N, Perše M, Pleško J, Večerić-Haler Ž. Kojc N, et al. Biomed Res Int. 2018 Jul 25;2018:4074209. doi: 10.1155/2018/4074209. eCollection 2018. Biomed Res Int. 2018. PMID: 30148166 Free PMC article.

9

Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges.

Perše M, Večerić-Haler Ž. Perše M, et al. Biomed Res Int. 2018 Sep 12;2018:1462802. doi: 10.1155/2018/1462802. eCollection 2018. Biomed Res Int. 2018. PMID: 30276200 Free PMC article. Review.

10

The Role of IgA in the Pathogenesis of IgA Nephropathy.

Perše M, Večerić-Haler Ž. Perše M, et al. Int J Mol Sci. 2019 Dec 9;20(24):6199. doi: 10.3390/ijms20246199. Int J Mol Sci. 2019. PMID: 31818032 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page